20+ years of experience specializing in providing evidence-based solutions that target the reduction of pathogens and causative agents of infectious diseases. Primary focus toward the control of emerging 'super bugs' in the health care space such as C.diff, CRE, MRSA, VRE, & Acinetobacter through the use of UV (UV-C) disinfection technolgoy. In addition, focus on the role of waterborne pathogens e.g. Legionella, Pseudomonas, Stenotrophomonas Maltophila, etc. Extensive contacts throughout North America in the health care space to include:Transplant Centers (solid organ and BMT) acute care, long term care and the US Federal government at both VA and DoD. Current distribution channels with partners and offices throughout the US. Specialties: Infectious Diseases, Infection Control, and Facilities Management.

20+ years of experience specializing in providing evidence-based solutions that target the reduction of pathogens and causative agents of infectious diseases. Primary focus toward the control of emerging 'super bugs' in the health care space such as C.diff, CRE, MRSA, VRE, & Acinetobacter through the use of UV (UV-C) disinfection technolgoy. In addition, focus on the role of waterborne pathogens e.g. Legionella, Pseudomonas, Stenotrophomonas Maltophila, etc. Extensive contacts throughout North America in the health care space to include:Transplant Centers (solid organ and BMT) acute care, long term care and the US Federal government at both VA and DoD. Current distribution channels with partners and offices throughout the US. Specialties: Infectious Diseases, Infection Control, and Facilities Management.

Gunner Lyslo is the founder and CEO of Surfacide, LLC. He has been a leader over the past 20 years in the infection control & disinfection space with specific attention toward the development of evidenced-based disinfection modalities. Gunner’s early career focus was toward the development of technologies to address the infectious disease role that Legionella and other waterborne pathogens present when colonizing water distribution systems. His current focus is directed toward the critical impact that pathogens such as SARS CoV-2, (COVID-19) C.diff, MRSA and other multi-drug resistant pathogens present when colonizing the patient environment. Gunner has been issued 10 US patents related to UV disinfection by the United States Patent & Trademark office and 5 International Patent authorities with an several additional patents pending. The Surfacide Helios system is unique as it is the only patented, triple emitter UV-C disinfection system that addresses the challenges of shadows, distance and labor--all variables that are inherent challenges to all first-generation systems.